Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Tau Ser356 in Alzheimer’s Disease and NUAK Inhibition
2026-09-25
The study links phosphorylated tau at Ser356 (p-tau Ser356) with Alzheimer’s disease pathology, showing a Braak stage-dependent increase and frequent localization in neurofibrillary tangles and near synapses. It also finds that NUAK inhibition with WZ4003 lowers p-tau Ser356 in live human brain slices, while mouse and human slice cultures respond differently—an important caution for preclinical therapeutic studies.
-
Tin Mesoporphyrin IX: From HO Activity to Translation
2026-09-24
Heme oxygenase links heme turnover to signaling outputs that can shape disease biology. This article explains how Tin Mesoporphyrin IX (chloride) can help researchers test the role of HO catalytic activity, interpret emerging antiviral findings, and design more rigorous translational studies without confusing enzyme expression with enzyme function.
-
BPN-19186 and the Liver–Bone Redox Axis
2026-09-24
Explore how BPN-19186 can support carefully controlled studies of redox signaling and osteoclast biology. This article translates evidence for a hepatic sEH–Nrf2 liver–bone axis into practical experimental decisions while distinguishing established findings from compound-specific questions.
-
Mianserin HCl: Research Workflows and Assay Design
2026-09-23
Use Mianserin HCl to probe serotonergic and noradrenergic signaling, or to test how cyclodextrin complexation changes its cellular effects. A short placebo-controlled clinical study also offers practical ideas for separating mood-related endpoints from early sleep changes—while underscoring the limits of brief, sedative-supported trials.
-
EZ Cap™ Human PTEN mRNA Workflow
2026-09-23
Build reproducible PTEN restoration assays with a Cap 1, poly(A)-tailed transcript designed for efficient translation and reduced innate immune stimulation. This workflow connects controlled cell-based cancer research with emerging lipid nanoparticle and transdermal delivery strategies.
-
CAY10499: Inhibitor of Human Hormone Sensitive Lipase
2026-09-22
CAY10499 enables parallel interrogation of HSL, MGL, and FAAH in lipid-flux, endocannabinoid, and immunometabolic assays. This workflow-focused guide shows how to connect lipase activity with extracellular vesicle-driven macrophage biology while preserving the controls needed to distinguish direct enzyme inhibition from downstream cell-state effects.
-
Leucovorin Calcium in Tumor–Stroma Translation
2026-09-22
Leucovorin Calcium is more than a methotrexate rescue reagent: it can serve as a mechanistic probe for folate dependence, rescue biology, and stromal modulation in patient-derived gastric cancer assembloids.
-
Rewiring Lipid Flux in EV-Driven Tumor Immunity
2026-09-21
Extracellular vesicle-transferred ACLY links tumor metabolism to immunosuppressive macrophage differentiation in hepatocellular carcinoma. This article examines how CAY10499 can provide an orthogonal HSL/MGL perturbation strategy for separating lipid synthesis, fatty-acid mobilization, and endocannabinoid turnover in translational immunometabolism studies.
-
Acetylcysteine for 3D Redox and Cancer Models
2026-09-21
Acetylcysteine, also called N-acetyl-L-cysteine, can be used as a controlled redox perturbation in organoid–fibroblast assays rather than as a generic antioxidant additive. This workflow connects glutathione support, oxidative stress pathway modulation, and patient-specific chemoresistance testing while highlighting practical controls, dosing windows, and assay-interference risks.
-
Ibuprofen Toxicology and Biodegradation
2026-09-20
Jan-Roblero and Cruz-Maya frame ibuprofen as an emerging contaminant by connecting widespread use with aquatic and soil exposure, oxidative and genotoxic stress, and incomplete removal during wastewater treatment. Their review also evaluates bacterial biodegradation as a developing remediation strategy and identifies important gaps in environmental monitoring, mechanism-based toxicity testing, and treatment validation.
-
EZ Cap™ Human PTEN mRNA for Cancer Research
2026-09-19
EZ Cap™ Human PTEN mRNA provides a defined, Cap 1 and poly(A)-tailed format for transient PTEN restoration, pathway studies, and delivery-system screening. Its workflow value is especially clear when free mRNA transfection is compared with targeted carriers such as hyaluronate lipid nanoparticles in melanoma models.
-
PEG 400, Quercetin, and BCRP-Mediated Exposure
2026-09-18
The reference study shows that PEG 400 substantially increases quercetin and quercetin-3-O-β-D-glucuronide exposure by combining solubilization with changes in UGT1A9 metabolism and BCRP/MRP2 efflux. Its integrated pharmacokinetic, spatial imaging, cellular, and anti-inflammatory design provides a useful framework for interpreting excipient-mediated transporter effects while highlighting important limits to translation.
-
A-1210477: MCL-1 Inhibitor Workflow Guide
2026-09-18
A-1210477 provides a selective way to test whether cancer-cell survival depends on MCL-1-mediated suppression of mitochondrial apoptosis. This practical guide covers stock preparation, dose-response design, mechanism confirmation, combination studies, and troubleshooting for reproducible cancer research.
-
Proteoform-Specific Drug Interactions in Native Membranes
2026-09-17
The reference study introduces a native mass-spectrometry strategy for defining how membrane-protein proteoforms, lipid modifications, and drug interactions are linked in intact signaling environments. Its analysis of rhodopsin, G proteins, and PDE6 shows why off-target pharmacology can depend on proteoform state rather than protein identity alone.
-
Cy5-UTP for Fluorescent RNA Labeling
2026-09-16
Cy5-UTP, also called Cyanine 5-uridine triphosphate, is a fluorescent UTP analog for T7 in vitro transcription RNA labeling. Its reported 650/670 nm excitation/emission maxima support direct detection of labeled RNA, while the axonal RNP study provides a biological rationale for tracing RNA-associated transport without demonstrating use of this reagent.